The startup manufactures sterile injectable medications, specializing in single-dose liquid vials and pre-filled syringes produced through an automated filling process. This technology ensures the stability and longevity of medications, providing hospitals and healthcare units with safe and compliant injectable products for patient treatment.
Funding
$15M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Hospitals and healthcare providers face challenges in consistently accessing affordable, high-quality sterile injectable medications, especially those on the US FDA drug shortage list. Traditional pharmaceutical manufacturing processes can be prone to human error, potentially impacting product quality and dosing precision.
Solution
Medivant Healthcare manufactures sterile injectable medications in single-dose liquid vials and pre-filled syringes using fully automated, cGMP-compliant processes. The company focuses on producing affordable generic pharmaceuticals, including medications on the FDA shortage list, to ensure a consistent and reliable supply for hospitals and healthcare providers. Medivant's state-of-the-art facilities feature automated manufacturing tanks, filling machines, and terminal sterilizers, all operating under strict ISO and cGMP guidelines. By leveraging advanced technology and rigorous quality control, Medivant aims to reduce costs, improve product quality, and enhance accessibility to essential injectable medications.
Target Audience
Medivant Healthcare primarily serves hospitals, healthcare providers, and pharmacies seeking a reliable and affordable supply of sterile injectable medications, including those experiencing drug shortages.
Features
- Fully automated manufacturing process minimizing human error and ensuring consistent product quality
- cGMP-compliant facilities with ISO 7 and ISO 5 environments for compounding and filling
- Manufacturing of single-dose liquid injectable vials in sizes ranging from 1ml to 30ml
- Production of pre-filled syringes with precise dosing and extended Beyond-Use Date (BUD)
- Terminal sterilization with a 10 log 6 overkill approach for enhanced product sterility
- In-house Water for Injection (WFI) system with SS316L orbital welded WFI loop
- High-speed semi-automatic inspection machine for vial inspection, ensuring particle-free products
- Inline labeling machine with serialization capabilities for pack-level tracking